Journal of Foot and Ankle Surgery (Asia Pacific)

Register      Login

VOLUME 2 , ISSUE 1 ( January-June, 2015 ) > List of Articles

CASE REPORT

Subcutaneous Foot Phaeohyphomycosis due to Alternaria alternata

Mithun Shriniwas Jakkan, Vikas Madhav Agashe, Alan Almeda

Citation Information : Jakkan MS, Agashe VM, Almeda A. Subcutaneous Foot Phaeohyphomycosis due to Alternaria alternata. J Foot Ankle Surg Asia-Pacific 2015; 2 (1):44-46.

DOI: 10.5005/jp-journals-10040-1028

Published Online: 01-06-2015

Copyright Statement:  Copyright © 2015; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract


PDF Share
  1. Phaeohypomycosis caused by alternaria infectoria in a renal transplant recipient. J Clin Microbiol 2001 May;39(5):1952.
  2. Cutaneous phaeohyphomycosism caused by alternaria alternata: case report. Case Reports in Dermatological Medicine 2011 Article ID 385803.
  3. Subcutaneous phaeohyphomycosis in a renal transplant recipient succesfully treated with voriconazole. Acta Dermato-Venerologica 2009;89(6):657-658.
  4. Phaeohyphomycosis, emerging as a common cause of diagnostic dilemmas. Int J Med Health Sci 2014 Apr;3(2):150-152.
  5. Cutaneous phaeohyphomycosis due to alternaria alternata: case report. Mycoses 2002 Oct;45(8):338-340.
  6. Phaeohyphomycosis due to alternaria species in transplant recipients. Transpl infect Dis 2010 Jun;12(3):242-250.
  7. Treatment of subcutaneous phaeohyphomycosis and prospective follow-up of 17 kidney transplant recipients. J Am Acad Dermatol 2009 Dec;61(6):977-985.
  8. Biosynthesis of fungal melanins and their importance for human pathogenic fungi. Fung Genet Biol 2003 Mar;38(2):143-158.
  9. Alternaria infections: laboratory diagnosis and relevant clinical features. Clin Microbiol Infect 2008 Aug;14(8):734-746.
  10. Recurrent phaeohyphomycosis: a case report. J Clin Diagnos Res 2013 sep;7(9):2015-2016.
  11. Cutaneous infection caused by alternaria alternata in an immunocompetent host. Mikrobiyol Bul 2009 Jan;43(1):163-167.
  12. Phaeohyphomycosis in tertiary care cancer center. Clin Infec Dis 2009 Apr;48(8):1033-1041.
  13. Molecular taxonomy of the alternaria and ulocladium species from humans and their identification in routine laboratory. Mycoses 2002 Oct;45(8):259-276.
  14. Phaeohyphomycosis. Infect Dis Clin North Am 2006 sep;20(3):609-620.
  15. Pharmacokinetics and safety of voriconazole following intravenous- to oral-dose escalation regimens. Antimicrob. Agents Chemother 2002;46(8):2546-2553.
  16. In vitro evauation of voriconazole against clinical isolates of yeasts, moulds and dermatophytes in comparison with itraconazole, ketaconazole, ampotericin B and griseofulvin. Mycoses 1998 Sep-Oct;41(7-8):309-319.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.